EP07.04-19 Clinical and Molecular Profile and Risk Factors of Stage IA NSCLC Relapsing after Radical Resection

Stage IA1-2-3 Non-Small Cell Lung Cancer (NSCLC) is currently indicated for upfront surgery, but long-term results highlight a recurrence rate up to 15-20%.Features of patients that experienced a recurrence after radical surgical treatment have not been fully analyzed in literature. The aim of this study is to identify risk factors, clinical and molecular profile of relapsing radically resected stage IA NSCLC.